August 5, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GeneDx Holdings Corp. (“GeneDx” or “the Company”) (NASDAQ: WGS). Investors who purchased GeneDx securities prior to April 16, 2025, and continue to hold to the present, are encouraged… read more
August 4, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AGCO Corporation (“AGCO” or “the Company”) (NYSE: AGCO). Investors who purchased AGCO securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether AGCO… read more
August 4, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Myriad Genetics, Inc. (“Myriad” or “the Company”) (NASDAQ: MYGN). Investors who purchased Myriad securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
August 4, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Innio N.V. (“Innio” or “the Company”) (NASDAQ: INIO). Investors who purchased Innio securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Innio… read more
August 4, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Carrier Global Corporation (“Carrier” or “the Company”) (NYSE: CARR). Investors who purchased Carrier securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
August 4, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Yum! Brands, Inc. (“Yum! Brands” or “the Company”) (NYSE: YUM). Investors who purchased Yum! Brands securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
August 4, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Albertsons Companies, Inc. (“Albertsons” or “the Company”) (NYSE: ACI). Investors who purchased Albertsons securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
August 4, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Badger Meter, Inc. (“Badger Meter” or “the Company”) (NYSE: BMI). Investors who purchased Badger Meter securities prior to April 18, 2024, and continue to hold to the present,… read more
August 3, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Calix, Inc. (“Calix” or “the Company”) (NYSE: CALX). Investors who purchased Calix securities prior to January 28, 2026, and continue to hold to the present, are encouraged to… read more
August 3, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CommVault Systems, Inc. (“CommVault” or “the Company”) (NASDAQ: CVLT). Investors who purchased CommVault securities prior to April 29, 2025, and continue to hold to the present, are encouraged… read more
August 3, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ChampionX Corporation (“ChampionX” or “the Company”) (NASDAQ: CHX). Investors who purchased ChampionX securities prior to February 29, 2024, and continue to hold to the present, are encouraged to… read more
August 3, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Parsons Corporation (“Parsons” or “the Company”) (NYSE: PSN). Investors who purchased Parsons securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Parsons has violated federal… read more
August 3, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Coastal Financial Corporation (“Coastal” or “the Company”) (NASDAQ: CCB). Investors who purchased Coastal securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Coastal has violated… read more
July 31, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pharming Group N.V. (“Pharming Group” or “the Company”) (NASDAQ: PHAR). Investors who purchased Pharming Group securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Pharming… read more
July 31, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Altria Group, Inc. (“Altria” or “the Company”) (NYSE: MO). Investors who purchased Altria securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Altria has violated… read more
July 31, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Teladoc Health, Inc. (“Teladoc Health” or “the Company”) (NYSE: TDOC). Investors who purchased Teladoc Health securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Teladoc… read more
July 30, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alnylam Pharmaceuticals, Inc. (“Alnylam” or “the Company”) (NASDAQ: ALNY). Investors who purchased Alnylam securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Alnylam has violated… read more
July 30, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of O-I Glass, Inc. (“O-I Glass” or “the Company”) (NYSE: OI). Investors who purchased O-I Glass securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether O-I… read more
July 30, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phathom Pharmaceuticals, Inc. (“Phathom” or “the Company”) (NASDAQ: PHAT). Investors who purchased Phathom securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Phathom has violated… read more
July 30, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Americold Realty Trust, Inc. (“Americold” or “the Company”) (NYSE: COLD). Investors who purchased Americold securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Americold has… read more
July 29, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ADTRAN Holdings, Inc. (“ADTRAN” or “the Company”) (NASDAQ: ADTN). Investors who purchased ADTRAN securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether ADTRAN has violated… read more
July 29, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dr. Reddy’s Laboratories Limited (“Dr. Reddy’s Laboratories” or “the Company”) (NYSE: RDY). Investors who purchased Dr. Reddy’s Laboratories securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
July 28, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Agios Pharmaceuticals, Inc. (“Agios” or “the Company”) (NASDAQ: AGIO). Investors who purchased Agios securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Agios has violated… read more
July 28, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zevra Therapeutics, Inc. (“Zevra” or “the Company”) (NASDAQ: ZVRA). Investors who purchased Zevra securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Zevra has violated… read more
July 27, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MapLight Therapeutics, Inc. (“MapLight” or “the Company”) (NASDAQ: MPLT). Investors who purchased MapLight securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether MapLight has violated… read more
July 27, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pathward Financial, Inc. (“Pathward” or “the Company”) (NASDAQ: CASH). Investors who purchased Pathward securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Pathward has violated… read more
July 27, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Rollins, Inc. (“Rollins” or “the Company”) (NYSE: ROL). Investors who purchased Rollins securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Rollins has violated federal… read more
July 23, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alignment Healthcare, Inc. (“Alignment” or “the Company”) (NASDAQ: ALHC). Investors who purchased Alignment securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Alignment has violated… read more
July 21, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Telefonaktiebolaget LM Ericsson (“Ericsson” or “the Company”) (NASDAQ: ERIC). Investors who purchased Ericsson securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Ericsson has violated… read more
July 21, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating the proposed take-private acquisition of Distribution Solutions Group, Inc. (NASDAQ: DSGR) by newly formed entities controlled by LKCM Headwater Investments, LLC to determine whether the transaction is fair to DSG’s unaffiliated shareholders and whether DSG’s Special Committee and… read more